Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Microba Life Sciences Ltd
MAPMicroba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia. Address: 324 Queen Street, Brisbane, QLD, Australia, 4000
Analytics
Objectif de Cours de WallStreet
0.57 AUDRatio C/B
–Rendement du dividende
–Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés MAP
Analyse des dividendes MAP
Croissance des dividendes sur 5 ans
–Croissance continue
–Ratio de distribution Moyenne sur 5 ans
–Historique des dividendes MAP
Valorisation des titres MAP
financières MAP
Résultats | 2019 | Dynamique |